Cancer Diagnostics Market set to exceed USD 156 billion by 2024

Jun 13, 2019

Increasing government initiatives to spread awareness pertaining to benefits of early diagnosis will boost cancer diagnostics market growth over the forecast timeframe.

Delaware, Selbyville - June 13, 2019 /MarketersMedia/ —

Cancer Diagnostics Market is set to exceed USD 156 billion by 2024; according to a new research report.
Increasing prevalence of cancer across the globe will be major driving factor for cancer diagnostics market. World Health Organization reported that cancer accounted for 8.8 million deaths in 2015 and was second leading cause of mortality. Unhealthy eating habits and changing lifestyle are further expected to boost prevalence in near future rendering significant positive impact on demand for better cancer diagnostic methods.

Increasing government initiatives to spread awareness pertaining to benefits of early diagnosis will boost cancer diagnostics market growth over the forecast timeframe. Awareness and accessibility of cancer diagnostic products is lower in developing and underdeveloped regions. Private as well as government organizations are conducting awareness campaigns to educate people regarding the importance of early diagnosis. Such activities will influence industrial growth. For instance, Roche in partnership with China Cancer Rehabilitation Society (CCRS) conducted ‘Run for Her' campaign to raise awareness about mammography.

Request a sample of this premium report titled at https://www.marketstudyreport.com/request-a-sample/859978/?utm_source=MM-VHS

Recent technological advancements enabling quick and accurate diagnosis will propel cancer diagnostics market growth. Patients are receiving treatment specifically tailored with accordance to their genetic makeup with the help of diagnosis based of next generation sequencing and liquid biopsy. Advent of such technologies in near future will support industry growth.

However, prohibitive cost of diagnosis is hampering adoption rates in countries with low income levels. Risk of radiations exposure will further impede market growth over the forecast period.

Imaging application segment held largest revenue share in 2016 and the trend is expected to continue over the forecast timeframe owing to wide range of applicability of imaging devices to detect majority of cancer types. Advent of technologically advanced devices such as computed tomography and positron emission tomography devices will positively impact market growth. These devices provide high quality imaging at lower radiation dose. The side effects associated with usage of some conventional imaging devices due to radiation exposure will hinder segment growth to some extent.

The liver-lung cancer application segment accounted for majority of market share in 2016. The segment growth is largely supported by increasing prevalence due to changing dietary habits such as increasing alcohol consumption and smoking.

U.S. dominated cancer diagnostics market in 2016, due to high research and development activities focused at developing better diagnostic methods. Presence of leading medical technology and biotechnology firms coupled with high adoption rates of technologically superior diagnostic methods will drive the U.S. cancer diagnostics market growth over the forecast timeframe.

China cancer diagnostic market should witness robust growth due to presence of large patient pool and increasing disposable income. Growing awareness pertaining to benefits of early diagnosis will propel market growth. However, being a price sensitive market, inflated cost of some advanced diagnostic tests may limit regional growth to some extent.

Request a discount on standard prices of this premium report titled at https://www.marketstudyreport.com/check-for-discount/859978/?utm_source=MM-VHS

Some of the key industry players operating in global cancer diagnostics market are Sienna Cancer Diagnostics, F. Hoffmann-La Roche, Becton, Dickinson and Company, C.R. Bard, Qiagen, Abbott Laboratories, Hoffmann-La Roche, Thermo Fisher Scientific, Siemens AG, Bio Rad Laboratories, GE Healthcare, Illumina, Koninklijke Philips, Toshiba Medical Systems Corporation, Agilent Technologies, and Hologic. Industry players are trying to garner higher market share through various organic as well as inorganic growth strategies. The companies in the industry are further trying to develop cost-effective and accurate diagnostics methods to get a competitive edge.

Report Content

Chapter 1. Methodology

1.1. Methodology

1.1.1. Initial data exploration

1.1.2. Statistical model and forecast

1.1.3. Industry insights and validation

1.1.4. Market definition and forecast parameters

1.2. Data sources

1.2.1. Secondary

1.2.2. Primary

Chapter 2. Executive Summary

2.1. Cancer diagnostics industry 360 degree synopsis, 2013 - 2024

2.1.1. Business trends

2.1.2. Application trends

2.1.3. Cancer type trends

2.1.4. End-use trends

2.1.5. Regional trends

Chapter 3. Cancer Diagnostics Industry Insights

3.1. Industry segmentation

3.2. Industry landscape, 2013 - 2024

3.3. Industry impact forces

3.3.1. Growth drivers

3.3.2. Industry pitfalls & challenges

3.4. Growth potential analysis

3.4.1. By application

3.4.2. By cancer type

3.4.3. By end-use

3.5. Regulatory landscape

3.5.1. U.S

3.5.2. Europe

3.6. Porter's analysis

3.7. Competitive landscape, 2016

3.7.1. Business overview

3.7.2. Revenue analysis

3.7.3. Product landscape

3.7.4. Strategy dashboard

3.8. PESTEL analysis

Chapter 4. Cancer Diagnostics Market, By Application

4.1. Global cancer diagnostics market share, by application, 2016 & 2024

4.2. Tumor biomarkers tests

4.2.1. Market estimates and forecast, by region, 2013 - 2024

4.3. Imaging

4.3.1. Market estimates and forecast, by region, 2013 - 2024

4.3.1.1. Ultrasound and Radiology

4.3.1.1.1. Market estimates and forecast, by region, 2013 - 2024

4.3.1.2. Mammography

4.3.1.2.1. Market estimates and forecast, by region, 2013 - 2024

4.3.1.3. MRI Scan

4.3.1.3.1. Market estimates and forecast, by region, 2013 - 2024

4.3.1.4. PET Scan

4.3.1.4.1. Market estimates and forecast, by region, 2013 - 2024

4.3.1.5. CT Scan

4.3.1.5.1. Market estimates and forecast, by region, 2013 - 2024

4.3.1.6. SPECT & Others

4.3.1.6.1. Market estimates and forecast, by region, 2013 - 2024

4.4. Biopsy

4.4.1. Market estimates and forecast, by region, 2013 - 2024

4.5. Liquid Biopsy

4.5.1. Market estimates and forecast, by region, 2013 - 2024

4.6. Immunohistochemistry

4.6.1. Market estimates and forecast, by region, 2013 - 2024

4.7. In Situ Hybridization

4.7.1. Market estimates and forecast, by region, 2013 - 2024

Chapter 5. Cancer Diagnostics Market, By Cancer type

5.1. Global cancer diagnostics market share, by cancer type, 2016 & 2024

5.2. Bladder Cancer

5.2.1. Market estimates and forecast, by region, 2013 - 2024

5.3. Breast Cancer

5.3.1. Market estimates and forecast, by region, 2013 - 2024

5.4. Colon and Rectal Cancer

5.4.1. Market estimates and forecast, by region, 2013 - 2024

5.5. Endometrial Cancer

5.5.1. Market estimates and forecast, by region, 2013 - 2024

5.6. Kidney Cancer

5.6.1. Market estimates and forecast, by region, 2013 - 2024

5.7. Leukemia

5.7.1. Market estimates and forecast, by region, 2013 - 2024

5.8. Liver-Lung Cancer

5.8.1. Market estimates and forecast, by region, 2013 - 2024

5.9. Melanoma

5.9.1. Market estimates and forecast, by region, 2013 - 2024

5.10. Non-Hodgkin Lymphoma

5.10.1. Market estimates and forecast, by region, 2013 - 2024

5.11. Pancreatic Cancer

5.11.1. Market estimates and forecast, by region, 2013 - 2024

5.12. Prostate Cancer

5.12.1. Market estimates and forecast, by region, 2013 - 2024

5.13. Thyroid Cancer

5.13.1. Market estimates and forecast, by region, 2013 - 2024

5.14. Others

5.14.1. Market estimates and forecast, by region, 2013 - 2024

Complete report titled at https://www.marketstudyreport.com/reports/cancer-diagnostics-market

About Us:

Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.

Contact Info:
Name: Arun Hegde
Email: Send Email
Organization: Market Study Report
Address: 4 North Main Street, Selbyville, Delaware 19975 USA
Phone: 1-302-273-0910
Website: https://www.marketstudyreport.com/

Source URL: https://marketersmedia.com/cancer-diagnostics-market-set-to-exceed-usd-156-billion-by-2024/523987

Source: MarketersMedia

Release ID: 523987

More News

Nov 4, 2026

President Hồ Chí Minh Mausoleum reopens after restoration

The President Hồ Chí Minh Mausoleum reopened to the public and international visitors on November 3, after completing its 2026 periodic restoration plan for the mausoleum and the Monument to Heroes and Martyrs, announced the mausoleum's Command.

Nov 4, 2026

Phú Thọ residents preserve cultural identity while embracing integration

As international integration deepens, preserving cultural identity, promoting traditional values and showcasing the people of this ancestral land will help enhance Phú Thọ’s appeal and standing while reflecting its aspirations for development.

Nov 4, 2026

Michelle Loo’s 6 favourite Hong Kong noodle shops plus a nostalgic favourite

Hong Kong media veteran Michelle Loo Mik-suet has worked in radio, TV and print, written books and even acted in films. She spoke to Andrew Sun. I will say my taste reflects that of a very local Hongkonger. Truly every time I travel back to Hong Kong, the first thing I want to eat is a bowl of congee or noodles. When I crave something from my childhood, I will go to Hung Kee (Shop B2, Block B, Kwong Sang Hong Building, 6 Heard Street, Wan Chai. Tel: 3708 8715). I like the pork bone congee and...

Nov 4, 2026

A taste of Europe: Italian cheese and French charcuterie take centre stage in Việt Nam

In its second year in Việt Nam, the campaign built upon the initiatives of its inaugural year, featuring a business-matching event in HCM City as well as workshops for chefs in both HCM City and Hà Nội.

Nov 4, 2026

Who really runs the fashion industry?

The industry may run on creativity, but it operates within rules written by governments

Nov 4, 2026

Camille Prats pens heartfelt post for son Nate on his college journey

Camille Prats is one supportive and proud momma!

Nov 4, 2026

Blackpink's Jisoo, Twice's Nayeon to appear on variety show together

For the first time, Blackpink's Jisoo and Twice's Nayeon are making a variety show appearance together!

Nov 4, 2026

On stage this November

Classics return to the stage alongside powerful women-led historical musicals, plus independent companies staging hard-hitting work

Nov 4, 2026

The next beauty conversation isn't about skin, it's about your scalp

Target Pro by Watsons is proof that consumers are becoming more discerning, as the brand celebrates its 10th anniversary. The positive consumer response and influencer reviews of its consumer-focused anniversary activations and promotions demonstrate that people increasingly value science-backed, targeted solutions developed through Japanese innovation. The brand's continued success inspires the development of new products that address the evolving needs of its consumers. In line with its anniversary celebration, Target Pro by Watsons introduces Femtech Lab, a breakthrough hair care line that puts the spotlight on the scalp, recognizing that it needs as much care as the face and the rest of the body. Femtech Lab believes that the secret to healthy hair starts with a healthy scalp. Femtech Lab addresses women's health and beauty needs through AI-powered screening technology and laboratory expertise. Its advanced scalp care solutions cater to four scalp types: dry, oily, thinning-prone and sensitive. Femtech Lab offers products designed to address how changing needs and everyday factors, from hormonal shifts to environmental conditions, influence scalp and hair health. The brand also targets specific concerns, including stress-induced hair problems and postpartum hair loss. Its formulations aim to simplify scalp and hair care routines while providing targeted solutions. Like Target Pro by Watsons, Femtech Lab delivers reliable solutions developed through scientific and dermatological studies by Japanese experts. Femtech Lab offers four flagship products designed to care for hair from scalp to tip: Anti-Hair Fall Root Balance Scalp Serum (P1,199), Anti-Hair Fall Root Renew Scalp Serum (P1,199), Anti-Hair Fall & Clarifying Shampoo (P899), and Anti-Hair Breakage & Shining Conditioner (P899). The Anti-Hair Fall Root Balance Scalp Serum is clinically proven to reduce hair fall and scalp sebum while improving hair density in four weeks. It features the trademarked ingredients ScalpZen and Prunizen, which help address scalp concerns and promote stronger, fuller and thicker-looking hair. For those looking to promote hair growth and address graying hair, the Anti-Hair Fall Root Renew Scalp Serum offers another targeted solution. Formulated with Baicapil and Kerascalp, it promises visible results after 12 weeks of consistent use. Reset your scalp with the Anti-Hair Fall & Clarifying Shampoo, which features a clarifying and rebalancing formula. It contains salicylic acid, panthenol and niacinamide to help provide long-lasting oil control and improve hair volume. The Anti-Hair Breakage & Shining Conditioner complements the shampoo by helping strengthen and protect hair. It enhances scalp comfort while improving hair condition from root to tip. The formula also helps increase moisture, smoothness and shine. As with Target Pro by Watsons, consumers can turn to Femtech Lab for targeted and effective hair and scalp care. Its approach highlights the value of Japanese science-led expertise, focusing not only on surface-level aesthetics but also on formulations designed to nourish the scalp and hair. Femtech Lab represents the natural evolution of Target Pro by Watsons' mission to provide comprehensive skin and beauty care, recognizing that targeted solutions go beyond the face. It also reflects the brand's continued evolution and commitment to addressing women's changing beauty and wellness needs through targeted, science-led innovation. Discover Target Pro by Watsons' Femtech Lab products, available at Watsons branches nationwide and through the Watsons app. Learn more about incorporating targeted scalp and hair care into your routine with Target Pro by Watsons and Femtech Lab.

Nov 4, 2026

M2M wanted a better ending. They found a new beginning

With their friendship rekindled, Marit Larsen and Marion Raven went on tour—and are returning to Manila for more

Nov 4, 2026

Creating a cocktail begins with understanding its purpose

From personal preference to the perfect pour, it’s all a matter of taste. Take it from Rian Asiddao, bar director and co-founder of The Jury and Bar by East

Nov 4, 2026

How corn is being elevated in a-maize-ing creations at Hong Kong restaurants and bars

The hottest ingredient of 2026? It is not a new breed of truffle, chocolate-fed Wagyu, nor caviar on pearl spoons. Instead, this ingredient is far from new, dating back about 9,000 years: corn. Across New York, London and Japan, sweetcorn pastries, pastas and pizzas have captured the imagination of chefs, content creators and corn enthusiasts. In Hong Kong, the trend is no different, with a corn-focused eatery opening in the city’s Central neighbourhood and everything from corn shabu-shabu...